Reply to: "The predictive value of significant fibrosis for metabolic disturbances in patients with NAFLD"
- PMID: 33359898
- DOI: 10.1016/j.jhep.2020.12.020
Reply to: "The predictive value of significant fibrosis for metabolic disturbances in patients with NAFLD"
Conflict of interest statement
Conflict of interest The authors declare no conflicts of interest that pertain to this work. Please refer to the accompanying ICMJE disclosure forms for further details.
Comment on
-
Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH.J Hepatol. 2020 Jul;73(1):17-25. doi: 10.1016/j.jhep.2020.02.028. Epub 2020 Mar 6. J Hepatol. 2020. PMID: 32147361
-
The predictive value of significant fibrosis for metabolic disturbances in patients with NAFLD.J Hepatol. 2021 Apr;74(4):970-971. doi: 10.1016/j.jhep.2020.10.028. Epub 2020 Dec 16. J Hepatol. 2021. PMID: 33340576 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
